Signal transducer and activator of transcription 3 (STAT3) has recently emerged as a pivotal oncogenic driver of GBM because of its contribution to GBM genesis, malignant progression, stemness, and resistance to radiotherapy and Temozolomide chemotherapy [6,7,8,9,10,11,12]. The gene discussed is STAT3; the disease is glioblastoma.